Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in Haiti
Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
Anti-HIV treatment consisting of lamivudine/zidovudine (3TC/ZDV) and efavirenz (EFV) is the
current standard of care for initial treatment of HIV in most areas of the world. The purpose
of this study is to determine the best time to start this anti-HIV treatment in
treatment-naive adults in Haiti.
Phase:
N/A
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Treatments:
Efavirenz Lamivudine Lamivudine, zidovudine drug combination Reverse Transcriptase Inhibitors Zidovudine